Prognostic value of immunoinflammatory indicators and tumor markers for first-line chemotherapy in patients with non-small cell lung cancer
Combined assessment of immunoinflammatory and tumor markers improves prognostic accuracy in NSCLC patients receiving first-line chemotherapy and may guide individualized treatment strategies.
Authors
- Xingyu Zhou (ORCID: https://orcid.org/0000-0002-2761-6206)
Institutions
- Nantong University (CN)
- Affiliated Hospital of Nantong University (CN)
Publication Details
- Journal
- American Journal of Cancer Research
- Published
- 2025-01-01
- DOI
- https://doi.org/10.62347/zbgu2008
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Nantong University